Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 10 studies | 31% ± 11% | |
glutamatergic neuron | 9 studies | 44% ± 26% | |
ciliated cell | 9 studies | 28% ± 12% | |
endothelial cell | 7 studies | 24% ± 11% | |
interneuron | 7 studies | 37% ± 22% | |
GABAergic neuron | 7 studies | 42% ± 21% | |
oligodendrocyte | 7 studies | 25% ± 10% | |
microglial cell | 5 studies | 23% ± 4% | |
astrocyte | 5 studies | 33% ± 15% | |
neuron | 4 studies | 36% ± 15% | |
GABAergic interneuron | 3 studies | 24% ± 4% | |
granule cell | 3 studies | 16% ± 1% | |
epithelial cell | 3 studies | 24% ± 9% | |
glycinergic amacrine cell | 3 studies | 19% ± 3% | |
macrophage | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 290.51 | 2638 / 2642 | 98% | 2.31 | 691 / 705 |
esophagus | 100% | 199.22 | 1445 / 1445 | 98% | 2.55 | 179 / 183 |
thymus | 100% | 275.57 | 653 / 653 | 96% | 2.17 | 582 / 605 |
stomach | 100% | 136.45 | 359 / 359 | 95% | 2.73 | 272 / 286 |
intestine | 100% | 197.54 | 966 / 966 | 95% | 2.93 | 501 / 527 |
uterus | 100% | 256.77 | 170 / 170 | 93% | 2.36 | 425 / 459 |
lung | 99% | 182.78 | 573 / 578 | 93% | 2.09 | 1072 / 1155 |
ovary | 100% | 251.57 | 180 / 180 | 91% | 2.09 | 391 / 430 |
bladder | 100% | 260.71 | 21 / 21 | 91% | 2.44 | 458 / 504 |
adrenal gland | 100% | 245.94 | 257 / 258 | 91% | 3.11 | 209 / 230 |
kidney | 100% | 217.57 | 89 / 89 | 85% | 1.82 | 762 / 901 |
pancreas | 100% | 173.60 | 328 / 328 | 83% | 1.39 | 147 / 178 |
prostate | 100% | 190.17 | 245 / 245 | 82% | 1.38 | 414 / 502 |
breast | 100% | 220.80 | 459 / 459 | 81% | 1.68 | 900 / 1118 |
skin | 100% | 227.11 | 1808 / 1809 | 77% | 1.59 | 363 / 472 |
liver | 100% | 104.79 | 225 / 226 | 34% | 0.56 | 137 / 406 |
adipose | 100% | 208.45 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 232.09 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 175.41 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 136.84 | 794 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 108.48 | 821 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 1.95 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 83% | 1.66 | 24 / 29 |
eye | 0% | 0 | 0 / 0 | 65% | 1.03 | 52 / 80 |
peripheral blood | 55% | 90.52 | 513 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0006513 | Biological process | protein monoubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
GO_0044390 | Molecular function | ubiquitin-like protein conjugating enzyme binding |
GO_0005515 | Molecular function | protein binding |
GO_0030332 | Molecular function | cyclin binding |
Gene name | UBE3D |
Protein name | E3 ubiquitin-protein ligase E3D (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase E3D) (UbcH10-binding protein with a HECT-like domain) (Ubiquitin-conjugating enzyme E2C-binding protein) UBE2CBP protein (Ubiquitin protein ligase E3D) Ubiquitin protein ligase E3D |
Synonyms | H10BH UBE2CBP C6orf157 |
Description | FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome. . |
Accessions | ENST00000505226.1 ENST00000430071.6 ENST00000509102.5 ENST00000369746.2 ENST00000626828.1 Q7Z6J8 J3KMY4 H0Y359 ENST00000369747.8 D6RHY9 ENST00000237186.10 D6RD24 Q4G0X5 |